INTRODUCTION
'Reverse-phase' protein lysate microarrays (RPAs) are a microformat dot western blot (WB) that does not separate protein samples using electrophoresis, allowing for the protein expression of hundreds to thousands of samples to be monitored simultaneously in a quantitative manner 1 . This technique entails printing whole-cell fraction lysates in a microarray format to detect proteins of interest by immunochemistry, as illustrated in Figure 1 . Based on the concept that RPAs require only miniscule sample volume for multiplex protein detection, tissue lysates from various organs have also been analyzed for biomarker discovery and clinical diagnostics using this method [1] [2] [3] [4] . Another powerful application for which RPA can be used is monitoring protein dynamics as a function of time in response to different input types and doses across many samples. Such high-dimensional data acquisition can contribute to the identification of accurate molecular drug targets, as well as the examination of protein network theoretical models 5, 6 . RPAs are one of the few technologies that provide high-dimensional proteomic data in a prompt, quantitative and affordable manner [7] [8] [9] . (d) A portion of the collected samples are pooled and run on a 2D prep well western blot (WB), and (e) probed with various antibodies to determine specificity across the entire molecular weight range of collected samples 13 . This process may be necessary before large-scale sample collection with a smaller sample size under identical conditions. (f) A large number of samples are plated into 384-well or 1,536-well microtiter plates, which are (g) subsequently printed to nitrocellulose film slides using an Aushon BioSystems 2470 solid-pin microarrayer. (h) The printed slides are probed with specific primary antibodies screened (e) for specific protein detection. (i) Protein levels are quantified by using the DI 25 algorithm implemented in the freely available software packages P-SCAN and ProteinScan.
Cell signaling is a continuous biochemical process that takes place in response to stimulation. One prominent biochemical role is played by phosphorylation, a posttranslational modification. When phosphorylation takes place in response to a particular input, an upstream molecule first responds, and then downstream changes in phosphorylated protein levels follow. To trace such dynamic events, frequent (short-time interval) sample collections must be performed 5, 6, [10] [11] [12] . To determine the correct window in which protein levels exhibit these dynamic changes, preliminary WBs should be performed with a small number of samples taken from a wide range of both times and doses 13 . Information from these preliminary experiments helps to determine more precise time-and dose-concentration windows in which samples should be collected using shorter intervals.
Seven stages are involved in this protocol as described in Experimental design. In principle, the stages are aimed at lysing cell pellets from various conditions followed by micro-dot printing to be used for quantitative output when detected with specific primary antibodies. One of the most important stages is antibody screening because a dot blot does not account for the antibody's specificity. Hence, the limited number of antibodies which give an analyzable signal is a major constraint of the technology. However, RPAs are extremely powerful when many antibodies, identified as analyzable, are available. Previously, we reported the utility of RPAs including: (i) proteomic profiling 14 , (ii) diagnostic marker identification 15 , (iii) protein kinetic monitoring 6, 13 and (iv) experimental validation of theoretical models 5 . All these studies employ the same protocol, varying only by the type of samples used. Information for these applications may also be obtained by ordinary western blotting 16 , but the results are not quantitative and the throughput is low. WB, however, resolves the sample protein fractions by molecular weight, so the band result is more specific. Alternatively, ELISA may yield more sensitive quantitative results when an appropriate antibody pair is available, which may be relatively limited 17 . Overall, the advantage of RPAs is the throughput in terms of sample number; the disadvantage, however, is the restriction of information learned by antibody specificity and performance. It is extremely useful when one needs to investigate protein expression levels changing over variables such as time or input strength.
We stress that the following protocol focuses on collecting 'many samples' for examining relative changes of proteins within a cell, not in a collection of tissue snapshots or a panel of cell lines. Following is a detailed description of our large-scale sample collection method for quantitative protein expression analysis, using RPA for experimental validation of protein network models. An overview of the process has been illustrated as a flowchart in Figure 1 .
Experimental design Cell culture and stimulation. Cells are grown in T-25 flasks at 37 1C in the presence of 5% CO 2 in the appropriate medium. Split the cells as many times as necessary to obtain the desired number of flasks. Once the cells have been split to the optimal number of flasks (when the cell population is B70% confluent for each flask), prepare the stimulation medium or ready the stress equipment (e.g., g-ray or U.V. irradiator) according to the study design. Stimulating agents can be drugs, growth factors, irradiations and others 6, 12 . For time course studies, optimal stimulant is added to a set of flasks simultaneously and the flasks are then collected at different time points. For dose escalation studies, different doses of stimulus are added to a set of flasks and the set is collected at the same time. Although it is possible to culture cells in smaller format, cells must be cultured in a flask (allowing cells to be collected first as a pellet before lysis) in order to make as high a concentration as possible. Cells grown in a well of a microplate are not abundant enough to form a pellet, nor can be they lysed in a small lysate buffer volume because of the viscosity of resulting solution. To achieve high concentration of protein, we lyse 20 ml volume in a well-pellet from a T-25 flask (2-5 Â 10 6 cells) with a 20 ml Pink buffer (PB) (described in PROCEDURE). Do not stimulate or stress the cells until you are fully ready to begin the sampling procedure.
Sample collection.
We have found that each sample should generally be collected from a T-25 flask to minimize handling errors while yielding sufficient cell pellet volumes for the required concentrations used in RPAs. When the entire sample-collecting process is performed on ice, the protein levels and biochemical reactions are ideally preserved isentropically. To complete each sample collection process promptly, the apparatus and equipment should be arranged based on the individual experimentalist's ergonomics (e.g., PBS bottles should be placed at a minimum distance from the flask). It also becomes critical to build a mock sample collection to identify whether any physical limitations are significant.
Cell lysis. Collected cell pellets are lysed with PB 18 . PB was initially used for 2D gel electrophoresis, but it was found to be ideal for RPA use based on the following qualities: (i) the urea content keeps proteins denatured at room temperature (i.e., around 20 1C); (ii) DTT is less volatile than b-mercaptoethanol (a commonly used reducing agent); and (iii) CHAPS does not precipitate after repeated freeze-thaw cycles. The concentration of each chemical component is adjusted as appropriate in all wells of a microplate using 0.67Â dilution buffer such that only the protein concentration changes when twofold serial dilutions of the sample are made 14 .
RPA production. Although PB is advantageous for retaining protein status, the viscosity of the resulting lysate is a critical problem in RPA production using conventional arrayers. Moreover, sample evaporation is another obstacle in large-scale microarray printing because of the long sample exposure time in source plates. To address these issues, we used the Aushon BioSystems 2470 microarrayer, which can produce arrays with even the most viscous lysate material 7, 19 . The Aushon 2470 uses a solid-pin configuration, a humidity/temperature environmental control and an automated continuous slide/microplate supply system. The throughput of the arrayer and the ability of the system to handle high-viscosity samples enabled the creation of a high-density lysate array with 410,000 features. Initially, RPAs were produced by a pin-in-ring format GMS/Affymetrix 417 arrayer that is no longer available in the market. The Aushon 2470 has been developed to retain the advantages of the 417 and improve pin architecture as well as printing environmental control. The solid-pin printing system eliminates the potential for clogging that can occur in quill pins or piezo electric array systems.
Our current Aushon BioSystems 2740 RPA production system uses a 32-pin configuration (maximum of 48) that can print 32 fields containing 20 rows and 20 columns. Sample placement within the microtiter plate and array layout should be carefully designed, depending on the number of samples being studied and the purpose of the printing. Although the number of dilutions is completely up to one's study design, we choose 10-point twofold dilution series because: (i) more dilution points give a wide range of sample concentrations, which allow more accurate calculation of protein expression level; (ii) with 32-pin configuration, we can make up to 12 dilution points per microplate, but the 110-mm pin and 4.5-mm pin-pin spacing limits the maximum number of dilution points. A high-density, large-scale format of the RPA provides maximal use when the study design requires many different samples to be tested under identical conditions. Other formats are preferred for preliminary testing in terms of staining, printing and layout ( Table 1 ). The present sample collection protocol is designed to be used with a large-scale, high-density array design, which is the most powerful application of RPA in the context of monitoring protein dynamics 5, 6 . Options are presented for using 384-well microtiter plates as well as 1536-well microtiter plates, which are capable of holding four times as many extractions as 384-well plates.
Immunochemical signal detection. After the lysate is printed, an immunochemical method is performed for signal detection. RPA does not resolve protein fractions by molecular weight, so it is important to ensure that antibodies are specific to their target antigens in the protein lysate. To test many antibodies in a range of cellular conditions, we developed an efficient WB method, using strip membranes with pooled lysates from various conditions 13, 20 . The result was a large dataset correlating WB results to the samples used and to antibody-probing conditions, which led us to develop a relational database to aid in proper antibody selection 13 .
Antibody choice and screening. The selection of antibodies can be different for each study. Investigators must address the performance of a set of antibodies before each RPA experiment. For general use, we have published two open resource antibody databases (http://discover.nci.nih.gov/abminer 20 and http://mtt. uscancer.org 13 ) to display WB results for antibodies that produced single bands at the expected ranges. Although samples were tested exhaustively, they are still limited and it is strongly recommended for each investigator to screen antibodies against their current samples by WB before RPA experiment. Specific primary antibodies are chosen only when they generate a single predominant band in the WB against the lysates to be used for RPA. However, it is important to note that not all such antibodies work well with RPA. Often, antibody concentrations need to be increased, while some antibodies may require a longer incubation time or a different type of blocking. For instance, we have found that B50% of the commercially available antibodies yield quantifiable RPA output.
Data quantification. After immunostaining, protein expression is quantified using available software packages. Because most RPA signal detection methods use a specific primary antibody followed by catalyzed signal amplification colorimetric detection (CSA; DakoCytomation) (Box 1), the signal levels can be obtained using the reflective mode of an ordinary optical flatbed scanner 21 . Scanned images are then converted into numerical values by two freely available software packages, P-SCAN and ProteinScan (http://mttab.cancer.gov) 5, 6, 22 . The software quantifies the signal intensities of the scanned images for each spot and uses the DI 25 algorithm to eliminate background effects by looking at the difference in the linear range of each dose-response curve and computing a single protein expression value for each sample (Figs.  2a,b) . In contrast to other microarray formats, RPA requires additional processing because a single value for the expression of a protein needs to be calculated per protein per sample from a dose-response curve, which provides 10 data points per sample (Figs. 2c,d ). It should be noted that normalization of protein expression could carry over noise to some extent because of the . Autostainer (DakoCytomation) . Fluorescent scanner (optional) (428; Affymetrix) . Near-infrared scanner (optional) (Li-Cor Odyssey)
BOX 1 | CATALYZED SIGNAL AMPLIFICATION
REAGENT SETUP PB For the preparation of a 40-ml scale, take 21.6 g of urea and add 22. the end of the setup. The DAB solution (DakoCytomation, cat. no. K3468) is prepared by adding 20 ml of liquid DAB+ chromogen for every 1 ml of DAB substrate buffer. m CRITICAL Because DAB is an oxidized element, this step should be performed directly before its use. EQUIPMENT SETUP Aushon Biosystems 2470 Microarrayer Turn on the arrayer and set the humidity control on the control view to 80%. Set the number of plates and change the extraction setting to 10 sectors (Fig. 3a) . Modify the pin diameter and spacing to accommodate the sample set (i.e., for a high-density matrix set: pin diameter to 130 mm, x-axis spacing to 225 mm, y-axis spacing to 225 mm). This step does not change the actual pin size; rather, it is used to properly set the spacing between features. Set the printing replicate type to reflect the study design (Fig. 3b) . We use the setting horizontal with 2 replicates. Choose to use slide 10 as a blot slide to ensure that pin tips do not carry residual material. Follow by setting the number of slides to be printed on each platen according to the sample layout. Once the parameters are set, empty the carboy waste water and fill the wash fluid with DI water. Place the set number of slides on the platens and place them into the arrayer. ! CAUTION Use gloves to avoid getting fingerprints on the slide and for general safety. DAKO Autostainer The parameters of the DAKO Autostainer setup should be modified to the number of slides being stained. Fill the TBST and DI water containers. Keep all the reagents at 4 1C when they are not in use. Once the reagents are set up as described in the protocol below, keep them covered as long as possible during the setup. m CRITICAL Always keep the slides in a wet condition, either with blocking buffer or DI water until staining starts. PROCEDURE Sample collection after stimulation or stress TIMING 15 min for preparation, 6 min per sample collection point 1| Before sample collection, label 1.5-ml centrifuge tubes for each sample to be collected. m CRITICAL STEP Label time point, stimulation or stressed condition, dosage and replicate number for organization. The tubes are used as an intermediary step.
2| Set up 1,000-ml pipettes and tips, ice bucket and cell scraper. m CRITICAL STEP The protocol is a time-sensitive procedure; therefore, all materials should be set up before sample collection and placed within reach for an ergonomically effective position.
3| Put several 50-ml tubes of PBS on ice. Approximately 50 ml for 3 T-25 flasks is required for hand-pour rinsing.
4| When you reach the proper time point, remove the flask from its stimulation or stressed condition and immediately place on ice. m CRITICAL STEP All processes after taking flasks out of incubator need to be completed on ice or in a cold room. A slow transition from stimulation or stress point to the ice will result in inconsistent protein sampling. (vii) Wash the cells a third time with B5 ml of chilled PBS by pipetting several times to thoroughly resuspend the cells, and repeat Steps 5B(v) and 5B(vi). (viii) Pipette 1.5 ml of chilled PBS into the flask.
(ix) Create a 1.5-ml cell suspension by pipetting several times.
6| Pipette the 1.5-ml cell suspension from Step 5A(vi) or 5B(ix) into a prelabeled centrifuge tube from Step 1.
7|
Immediately place centrifuge tube on ice.
8| Centrifuge the chilled centrifuge tube at 6,000g for 30 s at 41C. ! CAUTION Make sure you see the cell pellet formed at the bottom of the tube.
9| Use a pipette to remove the PBS and immediately place the tube containing the cell pellet on dry ice. ! CAUTION Do not use a vacuum pump for aspiration.
10| Repeat this process for each sample. m CRITICAL STEP This process should be performed with multiple flasks simultaneously when biological replicates are being made. As each sampling process takes 6 min, a maximum of four flasks can be handled at once. ' PAUSE POINT The cell pellet may be stored at À80 1C for 2-3 months before proceeding.
Cell lysis TIMING 1 h, 20 min
11| Label a new set of 1.5-ml centrifuge tubes as 'protein lysate' tubes.
12| Bring Pink buffer to room temperature. m CRITICAL STEP Make sure that Pink buffer remains at room temperature for a long enough period of time. Gently mix the tube by inverting it to make sure all the contents are dissolved.
13| Bring cell pellet to room temperature.
14| Centrifuge the cell pellet briefly at 2,500g for 30 s at room temperature to make sure there is no residual PBS. If there is, remove it with a pipette.
15|
Estimate the cell pellet volume by comparing it with a known volume using 5, 10, 20 and 40 ml of visible material (i.e., food coloring) in an identical tube.
16| Lyse the cell pellet by pipetting an equal volume of Pink buffer (the volume amount estimated in the previous step) into the cell pellet tube. m CRITICAL STEP Constant cell pellet volumes can be obtained with a fine degree of accuracy as long as they come from the same flask and the confluency of the cells is the same. However, the ratio of cell pellet volume to Pink buffer volume needs to be consistent throughout all the samples collected for the study. An ideal ratio would be 1:1, Pink buffer volume to cell pellet volume, which yields B10-20 mg ml À1 of lysate and equivalent to 0.67Â buffer component concentration. 19| Repeat the cell lysis steps for each sample.
20| Centrifuge all the cell lysates at 16,000g for 30 min at 4 1C to spin down the larger fractions of the molecules. At completion, there will be a small pellet visible. (Fig. 4a) . ! CAUTION Designate the plate with a name or number as not to confuse it with other plates. (ii) Place B8 ml of dilution buffer in a single well of a mini-incubation tray.
! CAUTION Tape the mini-incubation tray to the bench-top to secure its location. sample from sector 1 with the multichannel pipette. Transfer the 20 ml to the corresponding row in sector 2, in which the volume will total 40 ml, resulting in a twofold dilution or proteins. (vi) Mix gently 3-5 times, and repeat the transfer sequentially until sector 10 (Fig. 4b) .
! CAUTION Do not create bubbles.
? TROUBLESHOOTING (vii) Discard 20 ml of mixed sample from sector 10 so that there will only be 20 ml remaining. (viii) Repeat the dilution series process for the next neat sample remaining, starting with sector 1 and ending at sector 10.
m CRITICAL STEP Eight sets of sample dilution can be made at single dilution series preparation process (micropipetter handles eight samples at once).
? TROUBLESHOOTING (B) 1536-Well microtiter plate setup (i) Mark all 1536-well plates in 8 by 16 well blocks, sectioning the plate into 12 sectors (Fig. 4c) . ! CAUTION Designate the plate with a name or number as not to confuse it with other plates. The extraction locations (where pins go into to take samples out) for a 1536-well plate interweave with every other well so each of the 10 sectors that are used will contain a total of four extraction locations. (ii) Mark the location of the upper left-hand well on the lid of the plate for each extraction numbering them from 40 to 1 (Fig. 4c) . (iii) Place B8 ml of dilution buffer in a single well of a mini-incubation tray.
! CAUTION Tape the mini-incubation tray to the bench-top to secure its location. (iv) Use a multichannel pipette (4.5-mm spacing) to transfer 10 ml of dilution buffer from the mini-incubation tray to each well in the set of sectors numbered 2 through 10 ( Fig. 4d) . ! CAUTION Tape the microtiter plate to the bench-top to secure its location. (v) Pipette 20 ml of neat sample (collected cell lysate) into each well sector 1.
! CAUTION 1536-Well plates hold a maximum of 22 ml per well.
? TROUBLESHOOTING (vi) Create twofold dilution samples using the middle eight channels of the multichannel pipette to transfer 10 ml from each of the 8 wells in each row of sector 1 to the corresponding wells in each of the subsequent sectors. m CRITICAL STEP Start dilution series with row D of sector 1, and pipette three times for mixing. Take 10 ml of the neat sample from sector 1 with the multichannel pipette and transfer the 10 ml to the corresponding row in sector 2, in which the volume will be a total 20 ml resulting in a twofold dilution of lysate. The final volume of is 10 ml. 25| To store the plates properly, wrap the plate in Parafilm and place on dry ice for 5-10 min, until the lysate is frozen.
26| Place the chilled plate in a plastic Ziploc bag and store the plates in À80 1C. ' PAUSE POINT The prepared microtiter plates may be stored for 1 year at À80 1C.
RPA printing TIMING Up to 18 h 27| Make sure the arrayer humidity is at 80%.
28| Take the plates from À80 1C and let them thaw for 10 min in a Ziploc bag and Parafilm.
29| Remove Ziploc bag and let sit for 15 min.
30| Remove Parafilm and let the plates reach room temperature (about 10 min). ! CAUTION Do not remove the lid.
31| While the microtiter plates are thawing, fill the water reservoir with DI water, making sure the waste water is empty.
32| Load the plates according to the array layout. Use option A when using 384-well plates, and use option B for 1536-well plates. (A) Microarray printing with 384-well plates (i) Select the 384-well plate library before loading any initial plates (Fig. 3a) .
(ii) Load the required number of source plates by double-clicking on the plate interface. 33| Load up to 50 slides, including five blotting slides. Print the lysates with the microarrayer. ' PAUSE POINT Depending on the parameters used, this process can take up to 17 h, which may be done overnight.
Once the print is completed, the plates may be re-stored in À80 1C in the manner described above.
34| Remove the slides from the plates (optional protocols in Boxes 5 and 6 can be used at this point to estimate the total protein content of the slides). ' PAUSE POINT It is possible to store the printed slides in a sealed container containing desiccant at À20 1C. 38| Using an autostainer, set up the parameters to stain the appropriate number of slides using the recommended procedure and timing described in Box 1 (optional protocols in Boxes 2-4 can alternatively be used at this point to stain slides instead of the standard protocol in Box 1-see Experimental design for further information about the choice of staining and detection systems).
39| Empty water waste carboy and fill up DI water and TBST carboys. ! CAUTION The Autostainer GUI tells how much DI water and TBST volume is required; however, it is best to supply extra.
40| Prime the water pump.
41| Prime the buffer pump, and start the autostainer run (as described in Box 1 or Boxes 2-4 ). m CRITICAL STEP : Although this procedure is slightly complex, it may alternatively be handled step by step manually. ? TROUBLESHOOTING 42| When finished, rinse the slides with TBST and allow to air dry.
43| Label the slides with the antibody used and other pertinent information. 
ANTICIPATED RESULTS
When the procedure is performed as described, the pellet volumes across all samples collected are expected to be approximately equal. In general, the process yields about 40 ml of lysate from 2-3 million adherent cells in a T-25 flask (B70-80% confluency), resulting in a total protein concentration of B10-25 mg ml À1 . A Colloidal Gold Total Protein stain (Box 5) or SYPRO Ruby Total Protein Stain (Box 6) helps visualize the printed dilution curves when used on slides from Step 34. Detailed feature morphology can be seen with either an optical or a fluorescent microscope when the slides are stained in either one of these methods, allowing for quick visual inspection. Detection limit or sensitivity seems to be dependent on antibody affinity and how the epitope is presented in the nitrocellulose membrane, which cannot be measured precisely. Hence, it is hard to generalize the level of sensitivity as a technology specification. Linearity in a dose-response curve is often different depending on which antibody and which sample is used. We have shown the dose-response curves previously 6, 14 , as well as in Figure 2a . Since they are not a typical linear or logistic model, we employ DI 25 algorithm, which extracts the most representative protein expression value from each curve. On the basis of DI 25 values, we previously reported CVs between slides ranging from 5 to 10.5% and within a run at 3-4.4% among those which produced analyzable signals 6 . We eliminate low signal experiments (not necessarily a 'low abundance') from the analysis.
The final results are generated as quantifiable protein levels for many samples as detected by the specific antibodies used in the study. Note that protein signal detection should only be performed using antibodies known to work based on expected protein level changes 13, 20 . For instance, epidermal growth factor (EGF)-stimulated cells should show an initial increase in EGF-receptor phosphorylation briefly after stimulation using antibodies qualified to work against the same sample in WB Identify the error sources. Increase the number of replication of sample collection. Distribute samples to be printed to cancel these error sources (e.g., pins, rows, columns) (Spurrier, B.S. and Nishizuka, S., unpublished data). When the signal levels derived by the specific primary antibodies are normalized to total protein content, protein levels across slides may be comparable with one another; however, this approach can often be complicated. Such pitfalls can be largely avoided when the study is designed to investigate changing protein levels within a cell line based on time and dose, relative to one another on a single slide (Fig. 2d) . Our recent study demonstrated use of this protocol to show quantitative monitoring of the p53-Mdm2 feedback loop in response to g-irradiation, which was used to generate a kinetic model of the loop 5 . A set of differential equations were derived to express the feedback loop as a function of time. To evaluate the mathematical model, we used quantitative protein expression data from RPA. Quantitative p53 and Mdm2 (including phosphorylated p53 and phosphorylated Mdm2) protein expression over 8 h showed expected pulses in wild-type cells, whereas no pulses were seen in p53-knockout cells.
First, we determined mathematical parameters based on the result in wild-type cells. Subsequently, the p53 gene was knocked out in silico, allowing us to compare the behavior of Mdm2 in silico with its actual behavior in vitro. Interestingly, Mdm2's behavior in the in silico p53-knockout was quite similar to the actual experimental behavior. The results of this study suggest that the fundamental mechanism underlying the p53-Mdm2 feedback loop can be described in part by mathematical models and that quantitative protein data are an excellent reference for validating theoretical models of signal transduction. Such an approach may provide new means for the validation of in silico models, particularly in the context of identifying the molecular targets of drugs.
In summary, RPAs provide a unique opportunity to validate theoretical models, provided a large enough number of samples are collected properly. A well-described theoretical molecular network model always lays the groundwork for understanding signal transduction pathways. Rapid development of molecularly targeted drugs will increasingly necessitate a description of their detailed mechanisms at the protein network level. Clearly, the multidimensional proteomic data obtained by RPA will be a precious reference for theoretical biology and drug discovery. 
